Sun Pharma, Aurobindo recall products in US over defaulting norms
New Delhi: Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.
According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections.
According to the USFDA, the Princeton-based Aurobindo Pharma USA Inc is recalling the affected lot due to ''failed impurities/degradation specifications''.
The company initiated the nationwide Class II recall on January 14 this year.
Read Also - Unichem, Aurobindo Pharma recall Topiramate, Carvedilol respectively in US
The USFDA said the US-based arm of Sun Pharma is recalling 59,232 bottles of Chlorthalidone tablets, used for reducing excess fluid levels in the body.
As per the US health regulator, the New Jersey-based Sun Pharma Inc is recalling the affected lot due to ''foreign matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup''.
Read Also - Aurobindo Pharma launches COVID-19 drug Molnupiravir
The company initiated the Class II voluntary recall on February 7, 2022.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
According to industry estimates, the US generic drug market was estimated to be around USD 115.2 billion in 2019.
Read Also - Aurobindo Pharma in trouble for manufacturing lapses at API plant
Aurobindo Pharma Limited is a pharmaceutical company that manufactures generic pharmaceutical ingredients. The company works in six major therapeutic/product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. Aurobindo Pharma's marketing partners include AstraZeneca and Pfizer.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.